-
US orders additional 100 mn doses of Moderna’s COVID-19 vaccine
expresspharma
December 14, 2020
Total of 200 million doses ordered by the US government to date, it retains option to purchase up to an additional 300 million doses.
-
India prepares for 600 mn COVID vaccine shots; to use standard cold storage: VK Paul
expresspharma
December 14, 2020
India will deploy its vast election machinery to deliver 600 million doses of COVID-19 vaccines to the most vulnerable people in the next six to eight months through conventional cold chain systems, said Dr VK Paul, the expert leading the initiative.
-
Covishield can be available in first half of 2021
expresspharma
December 14, 2020
Serum Institute has currently applied with the DCGI for emergency authorization of Covishield in the country.
-
Moderna announces dosing of first adolescent participants in Phase II-III trials of COVID-19 vaccine
expresspharma
December 11, 2020
Moderna announced that the first adolescent participants have been dosed in the Phase 2/3 study of mRNA-1273, the company’s vaccine candidate against COVID-19, in adolescents ages 12 to less than 18.
-
Bharat Biotech to begin trial of intranasal Covid-19 vaccine
pharmaceutical-technology
December 10, 2020
Indian firm Bharat Biotech will be commencing Phase I trials of its intranasal Covid-19 vaccine candidate next month.
-
AstraZeneca’s vaccine shows efficacy in preventing symptomatic Covid-19
pharmaceutical-technology
December 10, 2020
AstraZeneca has reported that interim analysis from the Phase III programme of the Covid-19 vaccine, AZD1222, showed it is safe and effective at preventing symptomatic Covid-19.
-
Health Canada authorises Pfizer and BioNTech’s Covid-19 vaccine
pharmaceutical-technology
December 10, 2020
Health Canada has authorised Pfizer and its German partner BioNTech’s Covid-19 vaccine, BNT162b2, reaching a critical milestone in its fight against the pandemic.
-
US FDA staff back Pfizer COVID-19 vaccine data, authorisation likely soon
expresspharma
December 10, 2020
Data from the trial showed that the vaccine began conferring some protection to recipients even before they received the second shot, the FDA said.
-
MHRA issues anaphylaxis warning for Pfizer BioNTech vaccine
expresspharma
December 10, 2020
The Medicines and Healthcare Products Regulatory Agency (MHRA), Britain’s drug regulator said anyone with a history of anaphylaxis to medicine or food should not get the Pfizer-BioNTech COVID-19 vaccine, giving fuller guidance on an earlier allergy ...
-
UK commences roll-out of Pfizer’s COVID-19 vaccine
expresspharma
December 09, 2020
Britain approved the vaccine for emergency use less than a week ago, and is rolling it out through its National Health Service (NHS).